Central serous chorioretinopathy
Conditions
Interventions
577nm micropulse combined with TCM treatment group (within 500um):577nm micropulse combined with TCM treatment
577nm micropulse trearment group (within 500um):577nm micropulse trearment
Traditional Chinese medicine treatment group (within 500um):Traditional Chinese medicine treatment
blank control group (within 500um):N/A
Normal laser treatment group (beyond 500um):Conventional 532nm laser therapy
577nm micropulse trearment group (beyond 500um):577nm micropulse combined with TCM treatment
blank control group (beyond 500um):N/A
Sponsors
Lanzhou Aier Eye Housipital
Eligibility
Sex/Gender
All
Age
37 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Young and middle-aged patients; (2) aCSC was diagnosed by routine ophthalmic examination, fluorescent retinal angiography and OCT; (3) Onset time <6 months
Exclusion criteria
Exclusion criteria: (1) Unstable systemic diseases, including uncontrollable infections, body temperature >=38 degree, etc.; (2) Liver and kidney dysfunction; (3) pregnant and lactating women; (4) Investigators with poor compliance or severe mental or language disorders who are unable to complete the clinical trial protocol; (5) Those who have participated in clinical trials of other drugs in the past 3 months; (6) Patients with severe eye diseases such as glaucoma and uveitis (7) disagreed with the treatment plan; (8) Cases with incomplete data
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| macular central foveal thickness;best corrected visual acuity; | — |
Secondary
| Measure | Time frame |
|---|---|
| choroid central thickness;choroid paracentral thickness; | — |
Countries
china
Contacts
Public ContactWenjuan Duan
Lanzhou Aier Eye Housipital
Outcome results
None listed